/* Via Victoria: hard lock to the intended light colour palette on mobile browsers. */
A short illustrated guide from our family experience. Swipe sideways on your phone to see all six slides.
Inotuzumab ozogamicin (Besponza) is an antibody–drug conjugate targeting CD22-positive cells. Its use depends on the individual diagnosis and specialist treatment plan.
The six illustrated slides below retain their original Slovak text. This English overview is informational and is not a substitute for medical advice. Individual diagnosis and treatment decisions must be made by a qualified medical team.